Heron Therapeutics HRTX
$ 1.25
2.93%
Quarterly report 2024-Q3
added 11-12-2024
Heron Therapeutics Balance Sheet 2011-2024 | HRTX
Annual Balance Sheet Heron Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-22.8 M | -7.17 M | -80.1 M | -83.5 M | -52.1 M | -27.3 M | -116 M | 39.5 M | -73 M | -71.1 M | -71.3 M | -53 M | -17.9 M |
Long Term Debt |
2.8 M | 5.5 M | 8 M | 14.6 M | - | - | - | 50 M | - | - | - | - | - |
Long Term Debt Current |
3.08 M | 2.69 M | 2.42 M | 3 M | 1.93 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 14.6 M | 12.2 M | - | - | 50 M | - | - | - | - | - |
Total Current Liabilities |
79.7 M | 82.4 M | 71.1 M | 103 M | 96.7 M | 92 M | 103 M | 38.7 M | 19.7 M | 13.6 M | 6.99 M | 4.15 M | 3.69 M |
Total Liabilities |
256 M | 237 M | 228 M | 117 M | 109 M | 92 M | 103 M | 88.7 M | 19.7 M | 13.6 M | 6.99 M | 4.15 M | 3.69 M |
Deferred Revenue |
- | - | - | - | - | - | 2.76 M | 1.1 M | - | - | - | - | - |
Retained Earnings |
-1.91 B | -1.8 B | -1.61 B | -1.39 B | -1.17 B | -961 M | -783 M | -586 M | -413 M | -315 M | -239 M | -184 M | -160 M |
Total Assets |
223 M | 251 M | 306 M | 354 M | 513 M | 462 M | 234 M | 67.5 M | 138 M | 76.7 M | 75.9 M | 56 M | 19.4 M |
Cash and Cash Equivalents |
28.7 M | 15.4 M | 90.5 M | 105 M | 71.9 M | 31.8 M | 145 M | 13.4 M | 75.2 M | 72.7 M | 72.3 M | 53.5 M | 18 M |
Book Value |
-34 M | 13.6 M | 77.6 M | 236 M | 404 M | 370 M | 131 M | -21.3 M | 118 M | 63.1 M | 68.9 M | 51.8 M | 15.8 M |
Total Shareholders Equity |
-34 M | 13.6 M | 77.6 M | 236 M | 404 M | 370 M | 131 M | -21.3 M | 118 M | 63.1 M | 68.9 M | 51.8 M | 15.8 M |
All numbers in USD currency
Quarterly Balance Sheet Heron Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
522 K | 1.29 M | 2.04 M | 3.54 M | 4.16 M | 4.83 M | 5.5 M | 6.15 M | 6.78 M | 7.39 M | 8 M | 12.2 M | 13 M | 13.8 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
261 M | 256 M | 252 M | 257 M | 241 M | 232 M | 237 M | 250 M | 266 M | 250 M | 228 M | 234 M | 244 M | 115 M | 117 M | 117 M | 117 M | 117 M | 109 M | 109 M | 109 M | 109 M | 92 M | 92 M | 92 M | 92 M | 103 M | 78.1 M | 73.3 M | 87.4 M | 88.7 M | 88.7 M | 88.7 M | 88.7 M | 19.7 M | 19.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.36 M | 3.69 M | 2.6 M | 3.23 M | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.76 M | 5.56 M | 2.76 M | 2.76 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.92 B | -1.92 B | -1.91 B | -1.9 B | -1.87 B | -1.83 B | -1.8 B | -1.78 B | -1.73 B | -1.68 B | -1.61 B | -1.56 B | -1.51 B | -1.45 B | -1.39 B | -1.39 B | -1.39 B | -1.39 B | -1.17 B | -1.17 B | -1.17 B | -1.17 B | -961 M | -961 M | -961 M | -961 M | -783 M | -783 M | -783 M | -783 M | -586 M | -586 M | -586 M | -586 M | -413 M | -413 M | -413 M | -413 M | -315 M | -315 M | -315 M | -315 M | -239 M | -239 M | -239 M | -239 M | -184 M | -184 M | -184 M | -184 M | -160 M | -160 M | -160 M | -160 M |
Total Assets |
221 M | 218 M | 218 M | 229 M | 201 M | 221 M | 251 M | 272 M | 244 M | 274 M | 306 M | 352 M | 404 M | 311 M | 354 M | 354 M | 354 M | 354 M | 513 M | 513 M | 513 M | 513 M | 462 M | 462 M | 462 M | 462 M | 234 M | 234 M | 234 M | 234 M | 67.5 M | 67.5 M | 67.5 M | 67.5 M | 138 M | 138 M | 138 M | 138 M | 76.7 M | 76.7 M | 76.7 M | 76.7 M | 75.9 M | 75.9 M | 75.9 M | 75.9 M | 56 M | 56 M | 56 M | 56 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M |
Cash and Cash Equivalents |
25.7 M | 18.4 M | 20.4 M | 34.9 M | 13.5 M | 27.1 M | 15.4 M | 50.4 M | 48.6 M | 56.9 M | 90.5 M | 160 M | 191 M | 59.7 M | 105 M | 105 M | 105 M | 105 M | 71.9 M | 71.9 M | 71.9 M | 71.9 M | 31.8 M | 31.8 M | 31.8 M | 31.8 M | 145 M | 145 M | 145 M | 145 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 75.2 M | 75.2 M | 75.2 M | 75.2 M | 72.7 M | 72.7 M | 72.7 M | 72.7 M | 72.3 M | 72.3 M | 72.3 M | 72.3 M | 53.5 M | 53.5 M | 53.5 M | 53.5 M | 18 M | 18 M | 18 M | 18 M |
Book Value |
-40 M | -37.9 M | -33.8 M | -27.8 M | -39.3 M | -11.4 M | 13.6 M | 22.4 M | -21.7 M | 24 M | 77.6 M | 119 M | 160 M | 196 M | 236 M | 236 M | 236 M | 236 M | 404 M | 404 M | 404 M | 404 M | 370 M | 370 M | 370 M | 370 M | 131 M | 156 M | 161 M | 147 M | -21.3 M | -21.3 M | -21.3 M | -21.3 M | 118 M | 118 M | 138 M | 138 M | 76.7 M | 76.7 M | 76.7 M | 76.7 M | 75.9 M | 75.9 M | 75.9 M | 75.9 M | 56 M | 56 M | 56 M | 52.6 M | 15.8 M | 16.8 M | 16.2 M | 19.4 M |
Total Shareholders Equity |
-40 M | -37.9 M | -33.8 M | -27.8 M | -39.3 M | -11.4 M | 13.6 M | 22.4 M | -21.7 M | 24 M | 77.6 M | 119 M | 160 M | 196 M | 236 M | 236 M | 236 M | 236 M | 404 M | 404 M | 404 M | 404 M | 370 M | 370 M | 370 M | 370 M | 131 M | 131 M | 131 M | 131 M | -21.3 M | -21.3 M | -21.3 M | -21.3 M | 118 M | 118 M | 118 M | 118 M | 63.1 M | 63.1 M | 63.1 M | 63.1 M | 68.9 M | 68.9 M | 68.9 M | 68.9 M | 51.8 M | 51.8 M | 51.8 M | 51.8 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M |
All numbers in USD currency